ZINNAT 125mg / 5ml oral suspension pellets medication leaflet

J01DC02 cefuroxime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins

Cefuroxime is a second-generation cephalosporin antibiotic used to treat moderate bacterial infections. It is indicated for upper respiratory tract infections (such as sinusitis, tonsillitis, or pharyngitis), lower respiratory tract infections (bronchitis, pneumonia), urinary tract infections, otitis media, skin and soft tissue infections, as well as some bone and joint infections.

Cefuroxime works by inhibiting bacterial cell wall synthesis, killing the bacteria responsible for the infection. It is available in tablet, oral suspension, or injectable solution form.

Side effects may include nausea, diarrhea, abdominal pain, skin rashes, or allergic reactions. In rare cases, it can cause pseudomembranous colitis or severe hypersensitivity reactions. It is contraindicated in patients with allergies to cephalosporins or penicillins.

General data about ZINNAT 125mg / 5ml

Substance: cefuroxime

Date of last drug list: 01-06-2025

Commercial code: W65114001

Concentration: 125mg / 5ml

Pharmaceutical form: oral suspension pellets

Packing volume: 50ml

Product type: original

Price: 17.69 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: GLAXOSMITHKLINE TRADING SERVICES LIMITED - IRLANDA

Holder: GLAXOSMITHKLINE (IRELAND) LIMITED - IRLANDA

Number: 5184/2012/01

Shelf life: 2 years-after packing for marketing; suspensia reconstituita-10 days

Concentrations available for cefuroxime

1.5g, 125mg, 125mg/5ml, 1500mg, 250mg, 250mg/5ml, 500mg, 50mg, 750mg

Other substances similar to cefuroxime

Compensation lists for ZINNAT 125mg / 5ml GLAXO SMITH KLINE

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

17.69 RON

15.07 RON

2.62 RON